The comparison study of Lipo PGE1 preparations

Yakugaku Zasshi

Volumn 127, Issue 8, 2007, Pages 1237-1243

  Takenaga, Mitsuko ^a   Ohta, Yuki ^a   Tokura, Yukie ^a   Hamaguchi, Akemi ^a   Igarashi, Rie ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug delivery system; Lipid microspheres; Prostaglandin E1; Targeting

Indexed keywords

ALKALI; CALCIUM ION; CYCLODEXTRIN; DRUG ADDITIVE; GLYCEROL; HYDROCHLORIC ACID; LIPOPROSTAGLANDIN E1; MICROSPHERE; OLEANIC ACID; OLIVE OIL; PHOSPHATIDYLCHOLINE; PROSTAGLANDIN E1; SODIUM CHLORIDE; SODIUM HYDROXIDE; SOYBEAN OIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW; BLOOD FLOW VELOCITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG RETENTION; FEASIBILITY STUDY; FILTRATION; NONHUMAN; POROSITY; RAT;

ALPROSTADIL; ANIMALS; BLOOD FLOW VELOCITY; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; IRRITANTS; MALE; MICROSPHERES; RATS; RATS, WISTAR; SKIN;

EID: 34547644311     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.1237     Document Type: Article

References (28)

1. Mizushima Y., Drugs Exp. Clin. Res., 11, 595-600 (1985).
2. Mizushima Y., Yanagawa A., Hoshi K., J. Pharm. Pharmacol., 35, 666-667 (1983).
3. Hoshi K., Mizushima Y., Kiyokawa S., Yanagawa A., Drugs Exp. Clin. Res., 12, 681-685 (1986).
4. Mizushima Y., Shiokawa Y., Homma M., Kashiwazaki S., Ichikawa Y., Hashimoto H., Sakuma A., J. Rheumatol., 14, 97-101 (1987).
5. Katoh K., Kawai T., Narita M., Uemura J., Tani K., Okubo T., J. Pharm. Pharmacol., 44, 442-444 (1992).
6. Akahori H., Takamura T., Hayakawa T., Ando H., Yamashita H., Kobayashi K., Diabetes Res. Clin. Pract., 64, 153-159 (2004).
7. Sakaya H., Goto N., Nakamura T., Wakiya Y., Masada M., Abstracts of papers, the 125th Annual Meeting of the Pharmaceutical Society of Japan, 29-0815, 2005.
8. Goto N., Sakaya H., Nakamura T., Wakiya Y., Masada M., Abstracts of papers, the 125th Annual Meeting of the Pharmaceutical Society of Japan, 29-0816, 2005.
9. Igarashi R., Nakagawa M., Mizushima Y., Inflammation, 8, 243-246 (1988).
10. Igarashi R., Mizushima Y., Takenaga M., Matsumoto K., Morizawa Y., Yasuda A., J. Control. Release, 20, 37-46 (1992).
11. Igarashi R., Takenaga M., Takeuchi J., Kitagawa A., Matsumoto K., Mizushima Y., J. Control. Release, 71, 157-164 (2001).
12. Shoji Y., Mizushima Y., Yanagawa A., Shiba T., Takei H., Fujii M., Amino M., Drugs Exp. Clin. Res., 11, 601-609 (1985).
13. Igarashi R., Takenaga M., Matsuda T., Adv. Drug Deliv. Rev., 20, 147-154 (1996).
14. Shoji Y., Mizushima Y., Kameya T., Yakugaku Zasshi, 106, 605-608 (1986).
15. Suzuki K., Takahashi K., Matsuki Y., Kawakami M., Kawaguchi Y., Hidaka T., Sekiyama Y., Mizukami Y., Kawagoe M., Nakamura H., Jpn. J. Pharmacol., 60, 349-356 (1992).
16. Suzuki K., Clin. Exp. Immunol., 99, 479-485 (1995).
17. Mizushima Y., Hamano T., Haramoto S., Kiyokawa S., Yanagawa A., Nakura K., Shintome M., Watanabe M., Prostaglandins Leukot. Essent. Fatty Acids, 41, 269-272 (1990).
18. Kiyakawa S., Igarashi R., Iwayama T., Yanagawa A., Mizushima Y., Jpn. J. Inflamm., 7, 551-557 (1987).
19. Takenaga M., Igarashi R., Tsuji H., Mizushima Y., Jpn. J. Cancer Res., 84, 1078-1085 (1993).
20. Takenaga M., Nakagawa T., Igarashi R., Mizushima Y., J. Drug Target., 1, 293-301 (1993).
21. Kuwahara H., Sugihara T., Ohura T., Igawa H., Yamamoto Y., Scand. J. Plast. Reconstr. Surg. Hand Surg., 30, 23-28 (1996).
22. Egashira T., Kim Y. I., Takayama F., Kudo Y., Yamanaka Y., Free Radic. Biol. Med., 21, 353-356 (1996).
23. Takenaga M., Igarashi R., Matsumoto K., Takeuchi J., Mizushima N., Nakayama T., Morizawa Y., Mizushima Y., J. Drug Target., 7, 187-195 (1999).
24. Takenaga M., Igarashi R., Mizushima Y., J. Allergy Int., 14, 143-149 (2000).
25. Moriuchi-Murakami E., Yamada H., Ishii O., Kikukawa T., Igarashi R., J. Rheumatol., 27, 2389-2396 (2000).
26. Ohira H., Suzuki T., Shishido S., Tojo J., Miyata M., Obara K., Kasukawa R., Hepatol. Res., 19, 74-84 (2001).
27. Nishimura T., Nario K., Hosoi H., Eur. Arch. Otorhinolaryngol., 259, 253-256 (2002).
28. Kunihara M., Tsuchida K., Kaneko K., Suga H., Hasegawa T., Mochizuki S., Kawai K., Shiga A., Yamaguchi T., Arzneimittelforschung, 52, 358-364 (2002).